243 related articles for article (PubMed ID: 18635349)
1. Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist.
Cho K; Uneuchi F; Kato-Nakamura Y; Namekawa J; Ishizuka S; Takenouchi K; Nagasawa K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4287-90. PubMed ID: 18635349
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
[TBL] [Abstract][Full Text] [Related]
3. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
[TBL] [Abstract][Full Text] [Related]
4. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
Ishizuka S; Kurihara N; Hiruma Y; Miura D; Namekawa J; Tamura A; Kato-Nakamura Y; Nakano Y; Takenouchi K; Hashimoto Y; Nagasawa K; Roodman GD
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):269-77. PubMed ID: 18501591
[TBL] [Abstract][Full Text] [Related]
5. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C
Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902
[TBL] [Abstract][Full Text] [Related]
6. Remarkable effect of 2[small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23-lactones.
Saito N; Matsunaga T; Fujishima T; Anzai M; Saito H; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
Org Biomol Chem; 2003 Dec; 1(24):4396-402. PubMed ID: 14685312
[TBL] [Abstract][Full Text] [Related]
7. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
[TBL] [Abstract][Full Text] [Related]
8. Synthetic studies of (23S,25R)-1α,25-dihydroxyvitamin D
Akagi Y; Nagata A; Odagi M; Nagasawa K
J Steroid Biochem Mol Biol; 2018 Mar; 177():240-246. PubMed ID: 28757443
[TBL] [Abstract][Full Text] [Related]
9. Highly potent vitamin D receptor antagonists: design, synthesis, and biological evaluation.
Saito N; Kittaka A
Chembiochem; 2006 Oct; 7(10):1479-90. PubMed ID: 16871612
[TBL] [Abstract][Full Text] [Related]
10. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
11. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
12. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress of study on vitamin D analogs].
Kittaka A; Saito N; Takano M
Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
[TBL] [Abstract][Full Text] [Related]
14. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
Peräkylä M; Molnár F; Carlberg C
Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
[TBL] [Abstract][Full Text] [Related]
15. Novel A-ring homodimeric C-3-carbamate analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
Oves D; Fernández S; Verlinden L; Bouillon R; Verstuyf A; Ferrero M; Gotor V
Bioorg Med Chem; 2006 Nov; 14(22):7512-9. PubMed ID: 16879968
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel hapten derivatives of 1alpha,25-dihydroxy-vitamin D3 and its 20-epi analogue.
Blaehr LK; Björkling F; Calverley MJ; Binderup E; Begtrup M
J Org Chem; 2003 Feb; 68(4):1367-75. PubMed ID: 12585876
[TBL] [Abstract][Full Text] [Related]
17. Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure.
Yamada S; Yamamoto K; Masuno H; Ohta M
J Med Chem; 1998 Apr; 41(9):1467-75. PubMed ID: 9554880
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of TEI-9647 derivatives as Vitamin D3 antagonists.
Takenouchi K; Sogawa R; Manabe K; Saitoh H; Gao Q; Miura D; Ishizuka S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):31-4. PubMed ID: 15225742
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
